Dentists in Jefferson, LA Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Sean P Gaffney, DDS Dentist Medicare: Medicare Enrolled Practice Location: 825 S Clearview Pkwy, Jefferson, LA 70121 Phone: 504-733-1135 |
Dr. Gerard J Martin, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4027 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-833-2594 |
 Ms. Trang T Pham, RDH Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3809 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-833-2211 |
Dr. Teresita V Hernandez Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4612 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-733-9800 |
Dr. Charles Marion Jouandot, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3809 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-833-2211 Fax: 504-828-0802 |
News Archive
SmartTots announces recipients of inaugural round of research grants
SmartTots announced Robert Block, PhD and Caleb Ing, MD as the recipients of its inaugural round of research grants today. The research grants are intended to support investigations into the existence of a clinical signal suggesting poor neurocognitive outcomes as the result of early exposure to anesthesia. Drs. Block and Ing will be conducting separate studies both centered around determining the effects of anesthetics on early brain development. Both recipients will receive $100,000 to fund their studies.
Injections of adult stem cells could repair hearts
Injections of adult stem cells into damaged heart tissue significantly improved heart function in patients with severe congestive heart failure, according to results of the first prospective randomized trial of the experimental therapy presented today at the American Association for Thoracic Surgery.
Novel FAK inhibitors targeting binding site of VEGFR-3 reduce growth of pancreatic cancer cells
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
Brazilian startup to develop a low-cost high-performance COVID-19 diagnostic test
Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.
› Verified 5 days ago
Pharmacists
Clinical Social Workers
Occupational Therapists
Counselors
Dentists